![1803026-54-1: (2Z)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one](https://veeprho.com/wp-content/uploads/2022/07/2Z-1-5B5-6-Dihydro-3-trifluoromethyl-1-2-4-triazolo5B4-3-a5Dpyrazin-78H-yl5D-4-2-4-5-trifluorophenyl-2-buten-1-one.png)
1803026-54-1: (2Z)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one
(2Z)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one is an impurity of Sitagliptin which is a diabetes drug that acts by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. It also helps in decreasing the amount of sugar produced by liver.
Additional information on CAS 1803026-54-1
VE008780
1803026-54-1
C16H12F6N4O
390.28 g/mol
Sitagliptin
(2Z)-1-[5, 6-Dihydro-3-(trifluoromethyl)-1, 2, 4-triazolo[4, 3-a]pyrazin-7(8H)-yl]-4-(2, 4, 5-trifluorophenyl)-2-buten-1-one
N/A
“Sitagliptin Oral: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing – WebMD.” Webmd.com, 2022, http://www.webmd.com/drugs/2/drug-145697/sitagliptin-oral/details#:~:text=Sitagliptinisadiabetesdrug, ofsugaryourlivermakes..
In-stock
